arXiv Science⌕ Search

arXiv subjects

Shabbir Syed-Abdul

Publications and source records attributed to Shabbir Syed-Abdul.

3 recordsLinked to original sources

HippoMamba: A Mamba-augmented network for hippocampal segmentation and serial volumetry in Alzheimers disease

Hippocampal atrophy is among the earliest structural markers of Alzheimer's disease, and reliable hippocampal segmentation across serial MRI visits is a prerequisite for measuring it. We present HippoMamba, a network that combines a 3D convolutional encoder and decoder with a Mamba selective state space block at the bottleneck, designed to process one or more MRI visits of a subject. On the Medical Segmentation Decathlon hippocampus dataset (260 subjects, five-fold cross-validation), HippoMamba obtained a mean Dice similarity coefficient of 0.8861 $\pm$ 0.0094, the highest among six convolutional and transformer-based methods trained with the same folds and patch size, and its per-subject Dice was significantly higher than that of each method (Holm-corrected Wilcoxon tests, $p \leq 0.013$). Its mean 95th percentile Hausdorff distance (1.45 mm) and average surface distance (0.44 mm) were the lowest of the compared methods, although they did not differ significantly from those of Attention U-Net, and the Hausdorff distance did not differ significantly from that of SegResNet. Without retraining, the five-fold ensemble was applied to 600 T1-weighted sessions from 150 participants of the OASIS-3 cohort. In sessions meeting a registration quality criterion, predicted hippocampal volumes ranked consistently with FreeSurfer volumes (Pearson r = 0.778, 95% CI 0.699 to 0.838; ICC(3,1) = 0.772) but were systematically smaller by about 27%. In a pre-specified analysis of participants followed for at least two years, annualised volume change derived from per-visit segmentation was moderately correlated with that of FreeSurfer (r = 0.503, 95% CI 0.319 to 0.659), with a larger mean rate. These results support the use of HippoMamba for hippocampal segmentation and for ranking hippocampal volume within a cohort, with absolute volumes and rates of change interpreted relative to the reference method.

cs.CV↗

Modality Contribution Score - A Per-Patient Framework for Quantifying the Relative Diagnostic Contribution of Structural MRI and Amyloid PET in Alzheimer's Disease

Multimodal neuroimaging combining structural MRI and positron emission tomography (PET) captures complementary structure-function relationships across the Alzheimer's disease (AD) continuum, yet existing artificial intelligence systems produce a single diagnostic label without quantifying which imaging modality drove that decision for a specific patient. We introduce the Modality Contribution Network (MCNet) and the Modality Contribution Score (MCS), the first per-patient attribution framework quantifying the shift in modality dominance from structural atrophy to amyloid and metabolic dysfunction across the cognitively normal to MCI to AD continuum. MCS is normalised to unity per subject via modality ablation (MCS_MRI_i + MCS_PET_i = 1.0 for every subject i), providing an interpretable, clinically actionable score that fluid biomarkers cannot supply. Applied to 327 ADNI-3 participants balanced across cognitively normal, mild cognitive impairment, and AD groups, MCNet achieved competitive three-class staging performance (AUC=0.881). The MCS revealed a statistically significant monotonic gradient (Kruskal-Wallis p<0.0001), with increasing PET dominance from cognitively normal (MCS_PET 0.412+/-0.229) through MCI (0.489+/-0.289) to AD (0.671+/-0.426), validated against amyloid SUVR (r=0.172, p=0.006) and FDG metabolic biomarkers (r=-0.287, p=0.0005) from separate imaging pipelines. External replication in 1,073 independent OASIS-3 subjects confirmed cross-cohort generalisability (H=166.99, p<0.0001, eta^2=0.156). A mechanistic comparison with SHAP demonstrated that ablation-based MCS captures clinically meaningful modality dependence that deviation-based methods cannot. These findings position MCNet as a foundation for personalised imaging decisions, clinical trial stratification, and trustworthy AI in dementia care.

eess.IV↗

Disease universe: Visualisation of population-wide disease-wide associations

We apply a force-directed spring embedding graph layout approach to electronic health records in order to visualise population-wide associations between human disorders as presented in an individual biological organism. The introduced visualisation is implemented on the basis of the Google maps platform and can be found at http://disease-map.net . We argue that the suggested method of visualisation can both validate already known specifics of associations between disorders and identify novel never noticed association patterns.

q-bio.QM↗